ASSOCIATION BETWEEN ADHERENCE TO DIABETES MEDICATION AND GLYCEMIC CONTROL

Authors

  • Mustafa Nafea Al Kubais Al-Kindy College of Medicine, Baghdad-Iraq
  • Nageeb Abdul Galil Mohamed Hassan Ajman University, Baghdad-Iraq.
  • Mohammad Hossein Shamsain Ajman University, Baghdad-Iraq.

Keywords:

Glycemic control, Glycated Hemoglobin, diabetes medication, Delma Hospital

Abstract

Background: One of the most important factors affecting the glycemic control in Middle East is the extent of adherence of the patient to his/her diabetes medication(s).

Objective: This study aimed to assess the level of adherence to diabetes medication and patients’ glycemic control and to find out the association between the two variables.

Methods: A Cross sectional study on patients in Delma Hospital in the emirate of Abu Dhabi, United Arab Emirates including those who are 20 years and older and who were diagnosed since 2years or more. The adherence to diabetes medication was measured with Morisky Medication Adherence Scale while Glycated Hemoglobin was the indicator for glycemic control.

Results: 165 patients were interviewed, 15 of them were excluded due to insufficient data. Sample size was one of the limitations of this study generalizability. 40.7% of the studied population was between 51 to 65 years; more than 2/3 was male. 51.3% were using 4-6 medicines daily. Only 22% completed academic education. The mean (± SD) adherence score was 2.73 (± 2) while the mean (±SD) HbA1c was 7.58% (± 1.76%). The readings of HbA1c were significantly correlated with medication adherence score (P ? 0.01; r = 0.649).

Conclusion: The adherence to medications showed low to medium adherence. The good glycemic control group (HbA1c ? 6.5%) constituted only 26.7% of the studied samples versus 73.3% were in poor glycemic control (HbA1c ? 6.5%). The overall findings of this study showed low glycemic control and low adherence of patients to their medications.

Downloads

Download data is not yet available.

References

Al-Qazaz, H. K., Sulaiman, S. A. S., Hassali, M. A., Shafie, A. A., and Sundram, S. (2010). The 14-item Michigan Diabetes Knowledge Test: Translation and validation study of the Malaysian version. Practical Diabetes International, 27(6), 238-241a.

Asche, C., Lafleur, J., and Conner, C. (2011). A Review of Diabetes Treatment Adherence and the Association with Clinical and Economic Outcomes. Clinical Therapeutics, 33(1), 74-109.

Briesacher, B. A., Andrade, S. E., Fouayzi, H., and Chan, K. A. (2008). Comparison of drug adherence rates among patients with seven different medical conditions. Pharmacotherapy, 28(4), 437-43.

Cramer, J. A. (2004). A systematic review of adherence with medications for diabetes. Diabetes care, 27(5), 1218-24.

Del Prato, S., Felton, A. M., Munro, N., Nesto, R., Zimmet, P., Zinman, B., and Global Partnership for Effective Diabetes Management (2007). Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Recommendations from the Global Partnership for Effective Diabetes Management. International journal of clinical practice.Supplement, (157), 47-57.

Dezii, C. M., Kawabata, H., and Tran, M. (2002). Effects of once-daily and twice-daily dosing on adherence with prescribed glipizide oral therapy for type 2 diabetes. Southern medical journal, 95(1), 68-71.

Funnell, M. M., Brown, T. L., Childs, B. P., Haas, L. B., Hosey, G. M., Jensen, B., Maryniuk, M., Peyrot, M., Piette, J. D., Reader, D., Siminerio, L. M., Weinger, K., and Weiss, M. A. (2008). National standards for diabetes self-management education. Diabetes care, 31, 97-104.

International Diabetes Federation (2012). IDF Diabetes Atlas. 5.

Krapek, K., King, K., Warren, S. S., George, K. G., Caputo, D. A., Mihelich, K., Holst, E. M., Nichol, M. B., Shi, S. G., Livengood, K. B., Walden, S., and Lubowski, T. J. (2004). Medication adherence and associated hemoglobin A1c in type 2 diabetes. The Annals of Pharmacotherapy, 38(9), 1357-62.

Morisky, D. E., Ang, A., Krousel-Wood, M., and Ward, H. J. (2008). Predictive validity of a medication adherence measure in an outpatient setting. Journal of clinical hypertension (Greenwich, Conn.), 10(5), 348-54.

Morisky, D. E., Green, L. W., and Levine, D. M. (1986). Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence. Medical Care, 24(1), 67-74.

Rhee, M. K., Slocum, W., Ziemer, D. C., Culler, S. D., Cook, C. B., El-Kebbi, I. M., Gallina, D. L., Barnes, C., and Phillips, L. S. (2005). Patient adherence improves glycemic control. The Diabetes educator, 31(2), 240-250.

Simpson, S. H., Eurich, D. T., and Majumdar, S. R. (2006). A meta-analysis of the association between adherence to drug therapy and mortality. ACP journal club., 145(3), 80.

Skyler, J. S. (2004). Effects of Glycemic Control on Diabetes Complications and on the Prevention of Diabetes. Clinical diabetes : a publication of the American Diabetes Association., 22(4), 162.

Wild, S., Roglic, G., Green, A., Sicree, R., and King, H. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes care, 27(5), 1047-53.

Published

2015-01-15

How to Cite

Al Kubais, M. N. ., Hassan, N. A. G. M. ., & Shamsain, M. H. (2015). ASSOCIATION BETWEEN ADHERENCE TO DIABETES MEDICATION AND GLYCEMIC CONTROL. International Journal of Research and Development in Pharmacy & Life Sciences, 5(1), 1915-1920. Retrieved from https://ijrdpl.com/index.php/ijrdpl/article/view/201